Immunotech Laboratories, Inc. announced the company has relocated to a new Research & Development Lab facility in Monrovia, California. The new facility incorporates more laboratory use of the actual facility than the combined Administrative space at the previous Pasadena location. The new location also is geographically more conveniently located for the Immunotech team.

In light of the recent announcements stating the HIV-AIDS and Hepatitis C clinical trials using the company's patented "ITV-1" patented technology treatment by the Immunotech BG sister company, more clinical research and results testing is necessary. The new facility accommodates the additional lab space. Utilizing a combination of the clinical tests and results being conducted in Bulgaria alongside the results analysis here in the USA at the new facility, Immunotech plans to submit all the results from the Bulgarian clinical trials for US Food & Drug Administration "FDA" approval on a pre IND meeting.